X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
animals (22) 22
index medicus (21) 21
mice (20) 20
female (16) 16
male (10) 10
oncology (10) 10
protein kinase inhibitors - pharmacology (10) 10
janus kinase 2 - antagonists & inhibitors (9) 9
myelofibrosis (9) 9
cell line, tumor (8) 8
chemistry, medicinal (8) 8
hematology (8) 8
janus kinase 1 - antagonists & inhibitors (8) 8
mice, inbred balb c (8) 8
mutation (8) 8
primary myelofibrosis - drug therapy (8) 8
protein kinase inhibitors - therapeutic use (8) 8
pyrazoles - therapeutic use (8) 8
signal transduction - drug effects (8) 8
article (7) 7
rats (7) 7
treatment outcome (7) 7
abridged index medicus (6) 6
apoptosis - drug effects (6) 6
cell proliferation - drug effects (6) 6
cells, cultured (6) 6
chemokine (6) 6
pathway (6) 6
receptor (6) 6
adam proteins - antagonists & inhibitors (5) 5
aged (5) 5
antagonist (5) 5
antineoplastic agents - pharmacology (5) 5
antineoplastic agents - therapeutic use (5) 5
cytokines (5) 5
drug therapy (5) 5
expression (5) 5
hemic and lymphatic diseases (5) 5
jak2 inhibitor (5) 5
janus kinases - antagonists & inhibitors (5) 5
middle aged (5) 5
myeloproliferative neoplasms (5) 5
pharmacology & pharmacy (5) 5
phosphorylation - drug effects (5) 5
polycythemia-vera (5) 5
protein kinase inhibitors - administration & dosage (5) 5
rheumatoid-arthritis (5) 5
ruxolitinib (5) 5
spleen - drug effects (5) 5
spleen - pathology (5) 5
stat3 transcription factor - metabolism (5) 5
therapy (5) 5
adult (4) 4
aged, 80 and over (4) 4
apoptosis (4) 4
arthritis, experimental - drug therapy (4) 4
cell biology (4) 4
chemistry, organic (4) 4
immunology (4) 4
international-working-group (4) 4
janus kinase 2 - genetics (4) 4
janus kinase 2 - metabolism (4) 4
janus kinases (4) 4
kinases (4) 4
mmp (4) 4
monocyte chemoattractant protein-1 (4) 4
monocytes - drug effects (4) 4
pathogenesis (4) 4
primary myelofibrosis - mortality (4) 4
protein (4) 4
protein kinase inhibitors - chemistry (4) 4
proteins (4) 4
pyrazoles - administration & dosage (4) 4
pyrazoles - adverse effects (4) 4
pyrazoles - pharmacology (4) 4
quality-of-life (4) 4
receptor, erbb-2 - antagonists & inhibitors (4) 4
structure-activity relationship (4) 4
survival (4) 4
xenograft model antitumor assays (4) 4
activating mutation (3) 3
adam-10 (3) 3
administration, oral (3) 3
bone marrow (3) 3
breast-cancer (3) 3
cancer (3) 3
ccr2 (3) 3
cell line (3) 3
cells (3) 3
chemokine receptor 2 (3) 3
collagen-induced arthritis (3) 3
criteria (3) 3
cytokine (3) 3
diagnosis (3) 3
disease (3) 3
disease models, animal (3) 3
dogs (3) 3
dose-response relationship, drug (3) 3
double-blind (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2010, Volume 363, Issue 12, pp. 1117 - 1127
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 9, pp. 799 - 807
Journal Article
RSC Drug Discovery Series, ISSN 2041-3203, 2014, Volume 2014-, Issue 38, pp. 419 - 439
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2034 - 2034
Abstract Introduction: Acute graft-versus-host disease (aGVHD), a T cell-mediated immunological disorder is the leading cause of non-relapse mortality in... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2777 - 2777
Introduction: Post-translational histone modifications directly modify chromatin structure to influence a wide variety of cellular events including gene... 
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 09/2011, Volume 131, Issue 9, pp. 1838 - 1844
Journal Article
Blood, ISSN 0006-4971, 04/2010, Volume 115, Issue 15, pp. 3109 - 3117
Journal Article
1997, Factsbook series, ISBN 9780127099057, 197
How do you keep track of basic information on the proteins you work with? Where do you find details of their physicochemical properties, amino acid sequences,... 
Handbooks, manuals, etc | handbooks | Chemokines
eBook
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0199108
The Proviral Integration site of Moloney murine leukemia virus (PIM) serine/threonine protein kinases are overexpressed in many hematologic and solid tumor... 
SIGNAL-TRANSDUCTION | AML CELLS | CD25 EXPRESSION | ONCOGENIC PIM | MICE DEFICIENT | CELL LYMPHOMA | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | TYROSINE KINASES | ACUTE MYELOID-LEUKEMIA | DRUG-RESISTANCE | Cytarabine - pharmacology | Apoptosis - drug effects | Cytarabine - therapeutic use | Leukemia, Myeloid, Acute - pathology | Humans | Leukemia, Myeloid, Acute - metabolism | Antineoplastic Agents - therapeutic use | Hematologic Neoplasms - pathology | Dose-Response Relationship, Drug | Proto-Oncogene Proteins c-bcl-2 - metabolism | Animals | Signal Transduction - drug effects | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins c-pim-1 - antagonists & inhibitors | Cell Line, Tumor | Hematologic Neoplasms - drug therapy | Leukemia, Myeloid, Acute - drug therapy | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Phosphorylation - drug effects | Hematologic Neoplasms - metabolism | Cell proliferation | Cytokines | Analysis | Research | Protein kinases | Health aspects | Adenosine triphosphate | Cancer | Animal models | Phosphorylation | Transcription | Bcl-2 protein | Downstream effects | Leukemia | Serine | Xenotransplantation | Multiple myeloma | Intracellular signalling | AKT protein | Viruses | Kinases | Anticancer properties | Proteins | Signal transduction | Cytarabine | Antitumor agents | Xenografts | Bone marrow | Janus kinase | Tumorigenesis | Inhibition | Threonine | Isoenzymes | Myeloid leukemia | Patients | Substrates | 1-Phosphatidylinositol 3-kinase | Inhibitors | Adenosine kinase | Cell lines | Powder injection molding | In vivo methods and tests | Lymphomas | Solid tumors | ATP | Acute myeloid leukemia | Tumors
Journal Article
Haematologica, ISSN 0390-6078, 2015, Volume 100, Issue 4, pp. 479 - 488
Journal Article
International Journal of General Medicine, ISSN 1178-7074, 01/2014, Volume 7, pp. 89 - 101
Myelofibrosis (MF) is a rare chronic BCR-ABL1 (breakpoint cluster region-Abelson murine leukemia viral oncogene homologue 1)-negative myeloproliferative... 
Ruxolitinib | JAK inhibitor | Myelofibrosis | Extramedullary hematopoiesis | Myeloproliferative neoplasm | Complications and side effects | Diagnosis | Drug therapy | National libraries | Copyright clearance | Hematology | Pathogenesis | Leukemia | Kinases | Medicine | Copyright | Signal transduction | Medical prognosis | Stem cells | Bone marrow | Internet | Mutation | Web sites | Blood diseases | Tumors
Journal Article
16.